January 2026

Join WhatsApp Channel 

Crack GPAT — Prepare for GPAT Online 
Interview for the post of Researcher at Institute of Liver & Biliary Sciences
1 January 2026

Interview for the post of Researcher at Institute of Liver & Biliary Sciences

First class post graduate degree, including the integrated PG degrees or Second class post graduate degree, including the integrated PG degree with PhD.
1 January 2026
Fellowship opportunities in National Institute for Plant Biotechnology
Masters degree in the areas of Plant/ Agricultural Biotechnology and Molecular Biology, Plant Biotechnology, Plant Molecular Biology, Plant Biochemistry, Genetics and Plant breeding and related Biological Sciences.
1 January 2026
Macleods Walk In Drive for MPharm, MSc in Analytical Method Development, Bulk Drugs
Experience of Literature Survey, Identification of route of synthesis, Process optimization with respect to cost& quality scale up, documentation & characterization
1 January 2026
Interview for BPharm, BSc Freshers & Experience at Ipca
Handling and Reviewing of the documents related to instrument Le HPLC- Dissolution
1 January 2026
Walk in Drive for QC, QA, Production at Viatris Company - MPharm, BPharm, MSc apply
Mylan Laboratories Limited (A Viatris Company) is hiring for its OSD Manufacturing Facility at Pithampur, Indore.
1 January 2026
Peptides in Cosmetics

Vinay KumarVinay Kumar Singh. 
Head-Formulation
Kumar Organic Products Research Centre Pvt. Ltd.,
Bengaluru
Email : formulation_krc@kopresearchcentre.net

1 January 2026
Johnson & Johnson Finalizes USD 3.05B Halda Therapeutics Acquisition to Accelerate Next-Gen Cancer Therapies

Johnson & Johnson has officially completed its acquisition of Halda Therapeutics OpCo, Inc., a clinical-stage biotechnology company known for its innovative cancer-targeting technology, in a deal valued at USD 3.05 billion in cash.

1 January 2026
Enveric Biosciences Secures Key U.S. Patent to Broaden Neuropsychiatric Drug Pipeline
Enveric Biosciences, a biotechnology company developing next-generation small-molecule neuroplastogenic therapeutics, announced the issuance of a significant new U.S. patent that enhances its intellectual property portfolio and expands opportunities for advancing treatments in mental health disorders.
1 January 2026
Government bans high-dose Oral Nimesulide formulations in India
The Central Government has officially banned the manufacture, sale, and distribution of all oral formulations containing nimesulide above 100 mg in immediate-release dosage form for human use across India.